Monika Gappa is Professor of Paediatrics and Director of the Children’s Hospital, Evangelisches Krankenhaus Düsseldorf. She is the current President of the European Respiratory Society (ERS). Her main areas of interest are paediatric respiratory physiology, particularly assessment of lung function, early origins of lung disease, severe asthma, and allergy. She has been Associate Editor of Paediatric Pulmonology for many years and is on the Editorial Board of a number of respiratory journals. She has been active member of the ERS for more than 30 years, has contributed to a number of Task Forces and led the paediatric HERMES program. In 2020, she received the ERS Educational Award.
Medicine Degree at Universitat de Barcelona (1996) and Doctor in Public Health and Methodology of the Biomedical Research by the Universitat Autònoma de Barcelona (2002). Her research focuses on determinants of chronic respiratory disease (asthma and chronic obstructive pulmonary disease (COPD)) development and prognosis in children and adults, the definition and subtype characterization of these conditions and the use of advanced epidemiological methods (machine learning, causal methods).
She has conducted pioneering research on the role of physical activity in asthma and COPD, which merited several national and international awards, and is the coordinator of large multicentre national and international studies in respiratory epidemiology.
She has published more than 140 peer-reviewed scientific papers, and has served in several expert committees tasked with developing international policies on pulmonary rehabilitation and in national research evaluation committees.
She has ongoing close collaborations and projects with European researchers on physical activity and pulmonary rehabilitation as well as strategic alliances with
researchers from the Harvard School of Public Health (Boston, USA), the Epidemiology, Biostatistics and Prevention Institute (Zurich, Switzerland) and the Institut National de la Santé et de la Recherche Médicale (INSERM, France) in the areas of COPD and asthma epidemiology, as well as epidemiological methods.
A/Prof. Ruowen Ge
Associate Professor, Department of Biological Sciences, National University of Singapore
Ruowen Ge is a molecular cell biologist with more than 30 years’ experiences in biomedical research. Her research focuses on novel endogenous anti-angiogenesis and anti-inflammation proteins, investigating their biological mechanisms as well as therapeutic applications. She has published around 100 peer-reviewed papers, applied for 9 patents (3 of which have been awarded). Her lab is the first to identify ISM1 as an anti-angiogenic/anti-cancer protein and subsequently as an anti-inflammation protein critical for protecting lung homeostasis. She currently serves on the editorial board of BMC Respiratory Medicine, Cancers, Discover Oncology, and Scientific Reports. Her research has facilitated the establishment of two biopharma startup companies.
Clinical Professor Anne Goh Senior Consultant, Paediatric Respiratory Medicine Service and Allergy Service
Department of Paediatrics
KK Women’s and Children’s Hospital
She is the current President of the Asian Paediatric Pulmonology Society as well as the Assembly Head of the Paediatric Lung Disease Assembly of the Asia-Pacific Society of Respirology. She was the past President of the Singapore Paediatric Society from 2011-2020. She is a Clinical Professor of Duke-NUS Graduate Medical School and Associate Professor of the Lee Kong Chian School of Medicine and Yong Loo Lin School of Medicine. She is a reviewer for many international journals in Respiratory and Allergy as well as for the NMRC Exploratory and Developmental proposals.
She has clinical and research interests in respiratory and allergy and has authored several peer-reviewed papers as well as given many presentations at national and international courses and conferences.
Associate Professor Denise Goh obtained her medical degree (MBBS Honours) from NUS in 1993. She received her general paediatrics training at NUH from 1994 to 1996 and graduated in 1996 with two postgraduate degrees in paediatrics (Masters of Medicine in Paediatrics and Membership of the Royal College of Physicians). In 1999, she went on to do a 3-year Post-Doctoral Fellowship in Medical Genetics at Johns Hopkins University, USA. In 2002, she obtained her board certification in biochemical genetics and became a Fellow of the American College of Medical Genetics and a diplomate of the American Board of Medical Genetics. She obtained her Doctorate in Medicine in 2002, and is a Fellow of the Academy of Singapore.
A/Prof Goh is an Associate Professor at NUS. She is the chair of the Faculty Assessment committee, Paediatric Undergraduate Medical Director and the genetics module leader for the NUS Yong Loo Lin School of Medicine. She is the co-editor of the textbook Paediatric differential diagnosis – Top 50 problems.
A/Prof Goh currently practises as a Senior Consultant. She is a paediatrician and heads the specialised clinical genetic service that provides dedicated and holistic care to children and adults with or at risk of genetic disorders. She is involved in helping patients who are in need of financial assistance – she is the Chairman of the NUH Children’s Fund and a member of the NUH Children’s Liver & Rare Diseases Fund.
A/Prof Goh provides genetic expertise to other organisations such as the Ministry of Health.
Her research areas include the diagnosis and management of genetic conditions.
Professor Dr. Gerhard Grüber is a Full Professor at the School of Biological Sciences, Nanyang Technological University, Singapore. He obtained his PhD (Dr. rer. nat.) in Biochemistry from the Johannes Gutenberg-University Mainz, Germany, received his postdoctoral training as a DAAD-fellow in Biochemistry and Structural Biology at University of Oregon, USA and obtained as a DFG Habilitation Fellow his PhD (Dr.-habil.) at University of Osnabrück, Germany. He led the Tuberculosis excellence cluster TOPNet and is leading the Nontuberculous Mycobacteria excellence cluster TELMabNet. He is interest in relationships between the structure and mechanism(s) of mycobacterial enzymes related to bioenergetics, stress response and coenzyme A biosynthesis and of the pathogen Acinetobacter baumannii. His team uses a variety of structural, biochemical and biophysical approaches, paving the way for new structures, -targets, novel or improved inhibitors and lead compounds. He holds patents on novel anti-TB and anti-Mab targets and inhibitors targeting the mycobacterial F-ATP synthase.
Professor Graham Hall Director, Synergy Health Solutions
Professor, Curtin University
Honorary Research Associate, Telethon Kids Institute
Professor Graham Hall is respiratory physiologist with an interest in the translation of research outcomes into clinical practice, in particular newer respiratory function tests in the identification of early onset lung disease to improve the diagnosis and management of respiratory disease in children. Graham was the Co-chair of the Global Lung Function Initiative for a number of years and heavily engaged in the implementation of new reference ranges into clinical practice.
Prof Hall is the Managing Director of Synergy Health Solutions, holds an Honorary Research Associate appointment at Telethon Kids and is an adjunct Professor at Curtin University.
Professor Halpin is Consultant Physician & Honorary Professor in Respiratory Medicine at the University of Exeter. He was appointed as a Consultant in 1994. He has a busy clinical practice and for 13 years he was Clinical Lead for the Department in Exeter, overseeing the growth in its clinical and research activity. He is also Honorary Professor of Respiratory Medicine at the Observational and Pragmatic Research Institute (OPRI) in Singapore.
He is a member of the Board of Directors of the Global Initiative on Obstructive Lung Diseases (GOLD) and of the GOLD Science Committee. He was the Chairman and Clinical Expert for the COPD Guideline Development Group of the National Institute of Clinical Excellence (NICE) in the UK.
He studied at Oxford University (first class honours) & St Thomas Hospital Medical School, qualifying in 1986. He was awarded an MRC scholarship to undertake a D.Phil. in the Department of Human Anatomy at Oxford University, between his pre-clinical and clinical training. He trained in respiratory medicine at the Brompton Hospital in London.
He is a Fellow of Royal College Physicians, and a Member of the BTS, ERS & ATS.
He has served on various BTS committees.
In 2018 he was elected as a Fellow of ERS in recognition of lifetime excellence and contributions to research, education and clinical leadership in respiratory medicine.
His research is focussed on clinical aspects of COPD and asthma. He has published extensively and frequently gives presentations on COPD and asthma at lectures and meetings around the world. He was an Associate Editor of Thorax and is on the editorial board of American Journal of Respiratory & Critical Care Medicine as well as several other journals and is a peer reviewer for many others.
Toyohiro Hirai is Professor and Chair, Department of Respiratory Medicine, Graduate School of Medicine Kyoto University, and is also deputy director of Kyoto University Hospital, Japan. He has been Chairman of the Board of Directors of the Japanese Respiratory Society since 2022. He is a respiratory physician, specializing especially in pulmonary physiology and structure-function relationships in his research.
Anne Holland is Professor of Physiotherapy and Head of Respiratory Research at Monash University and Alfred Health in Melbourne, Australia. She leads a research program that aims to improve the lives of people with chronic lung disease using non-pharmacological treatments. Her recent clinical trials have tested novel models of pulmonary rehabilitation to improve access and uptake, including low cost home-based models and telerehabilitation. Professor Holland has published over 380 peer reviewed journal articles and her publications have been cited over 25 000 times. She was co-chair and senior author for the recently published Clinical Practice Guidelines on Pulmonary Rehabilitation from the American Thoracic Society . Professor Holland is currently the President of the Thoracic Society of Australia and New Zealand.
Jay Horvat is a Professor of Immunology and Microbiology and Deputy Head of School of Biomedical Sciences and Pharmacy (Research) at the University of Newcastle and Hunter Medical Research Institute. He leads a team that specialises in the development of the most highly representative animal and cell models of many infection & inflammation-induced diseases. In combination with complementary clinical investigations, his team have used their unique models to make major advances in understanding mechanisms of pathogenesis of respiratory and reproductive tract diseases and identify novel therapies. One of his research interests includes understanding how the inter-relationship between immunity and iron metabolism affects the pathogenesis and susceptibility to infection in lung diseases such as asthma, COPD and IPF.
Dr. Yoshikazu Inoue, M.D., Ph.D. Osaka Anti-Tuberculosis Association, Osaka Fukujuji Hospital, Osaka, Japan, advisor
National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, Japan, visiting researcher
Dr. Yoshikazu Inoue is a world-renowned pulmonologist and researcher, who is expert in Interstitial Lung diseases(ILD) and rare lung diseases such as pulmonary alveolar proteinosis(PAP), lymphangioleiomyomatosis(LAM)). From 1994 to 1997, he studied granulomatous lung diseases and pulmonary fibrosis at National Jewish Center for Immunology and Respiratory Medicine in Denver, Colorado. From 1997, he has worked in National Hospital Organization(NHO) Kinki-Chuo Chest Medical Center, Osaka, Japan. From 2011, he was an Invited Professor, Infection, Immunology and Oncology Cooperating Course, Graduate School of Medicine, Osaka University. From 2014, he was a group leader of the NHO Respiratory Network. From 2023, in addition to NHO Kinki-Chuo Chest Medical Center, he started to work in the Osaka Anti-Tuberculosis Association Osaka Fukujuji Hospital, as an advisor. He has conducted or collaborated many international/domestic official guidelines, global clinical trials, and international/domestic multicenter studies. He also has served patient societies of LAM, PAP and ILD.
Dr. Takashi Iwanaga graduated from Kindai University and obtained Doctor of Medicine in 1990, and was received Ph. D. in 1996. He studied clinic and conducted research in the field of respiratory medicine and allergy at the Department of Respiratory Medicine and Allergology, Kindai University Faculty of Medicine (1990~2021). He studied abroad at the Department of Respiratory Cell and Molecular Biology, Southampton General Hospital, University of Southampton (Prof. Stephen T Holgate) (2000-2002). Currently, He is a professor at Kindai University Hospital and director of the Center for General Medical Education and Training. He served as a member of the committee for Japanese Guidelines for Asthma Prevention and Management (2015, 2018), Management of Refractory Asthma (2019, 2023) and the Allergen Immunotherapy (2022). Since 2021, he has served as Head of the Clinical Allergy and Immunology Assembly of the Asia-Pacific Respiratory Society.
Dr. Hojoong Kim is Professor of Medicine at Sungkyunkwan University School of Medicine and Samsung Medical Center. Dr. Kim is a member of the Korean Medical Association, the Korean Society of Tuberculosis and Pulmonary Disease, as well as a member of international organizations such as the International Association for the Study of Lung Cancer, World Association for Bronchology, and the Asian Pacific Association for Bronchology. Although a major focus of his research and clinical activity has been in the field of Bronchology, Lung Cancer and Pulmonary Hypertension, Dr. Kim has also considerable expertise in IRB, Human Research Protection Plan and Safety issues in hospital management. Dr. Kim was appointed as a Congress President of 5th APCB held in Seoul, Korea at 2013.
2000.3 – 2006.2 M.D. College of Medicine, CHA University
2008.3 – 2010.2 M.S. College of Medicine, Graduate School, CHA University
2010.3 – 2017.2 Ph.D College of Medicine, Graduate School, CHA University
2006.3-2007.2 Internship in Bundang CHA Hospital
2007.3-2011.2 Residency in Department of Internal Medicine in Bundang CHA Hospital
2011.3-2012.5 Fellowship of Pulmonary and Critical care medicine in Asan Medical Center
2012.6-2014.2 Fellowship of Allergy and Clinical Immunology, in Ajou University hospital
2014.3-2022.2 Assistant Professor, Department of Pulmonology, Allergy and Critical care medicine, CHA Bundang Medical Center, CHA University
2022.3-present Associate Professor, Department of Pulmonology, Allergy and Critical care medicine, CHA Bundang Medical Center, CHA University
Woo Jin Kim is Professor of Internal Medicine and Chief of Environmental Health Center of Kangwon National University Hospital in Korea. He graduated from Seoul National University of Korea, College of Medicine. He has main research interest in COPD and environmental lung health issues, particularly genetic, environmental and epigenetic effects on chronic respiratory disease. He is a member of Korean Academy of Tuberculosis and Respiratory Disease and American Thoracic Society and also serves as head of Environmental, Occupational Health and Epidemiology assembly of Asia-Pacific Society of Respirology. He works as an associate editor for Tuberculosis and Respiratory Disease and BMC Pulm Med.
Professor Greg King is a staff specialist in the Department of Respiratory Medicine at Royal North Shore Hospital, Medical Director of the Respiratory Investigation Unit, and Research Leader of the Airway Physiology and Imaging Group at the Woolcock Institute of Medical Research. He is Conjoint Professor of Respiratory Medicine at the Northern Clinical School of the University of Sydney. He currently supervises PhD and other postgraduate students and uses complex lung function tests and imaging to study lung physiology and mechanics in airways diseases.
Dr Fanny Wai San Ko Consultant, Department of Medicine and Therapeutics, Prince of Wales Hospital Hong Kong
Honorary clinical associate professor, Department of Medicine and Therapeutics, The Chinese University of Hong Kong
Dr Ko is a specialist respiratory consultant physician in the Department of Medicine and Therapeutics at Prince of Wales Hospital in Hong Kong and the Honorary Clinical Associate Professor of the Faculty of Medicine of the Chinese University of Hong Kong.
Dr Ko’s main research interest is in asthma and COPD and has published more than 180 papers in peer-reviewed journals. She was elected as the Fellow of the European Respiratory Society in 2022. She was also a recipient of the Croucher Foundation Scholarship and Hong Kong Lung Foundation Fellowship.
Dr Ko is currently a member of the Scientific Committee of the Global Initiative for Asthma (GINA), Chairman of Hong Kong Lung Foundation, Senior Editor of Respirology and Medical Advisor of the Hong Kong Asthma Society. In addition, she is a Past President of the Hong Kong Thoracic Society and past Vice-President of the Hong Kong Institute of Allergy.
Dr. Jansen Koh obtained his MBBS from the National University Hospital of Singapore in 2001. He Obtained his MRCP (UK) in 2007 and EDIC in 2010. He is currently the Head of Department for Respiratory & Critical care Medicine Changi General Hospital. He is also the Deputy Head and Service Chief @CGH, Singhealth-Duke NUS Lung Center. He leads the Center for Performance Excellence Department in his capacity as Assistant Chairman Medical Board, Changi General Hospital. He is also the Chair for the Respiratory Chapter, College of Physicians, Academy of Medicine, Singapore. His specific interest in Respiratory & Critical Care is point of care ultrasonography, having obtained his certification from the American College of Chest Physicians. He is a Fellow at the Academy of Medicine Singapore, Royal College of Physicians Edinburgh and American College of Chest Physicians.
Associate Professor Mariko Siyue Koh (MBBS, MRCP, FAMS)
Senior Consultant in the Department of Respiratory and Critical Care Medicine, Singapore General Hospital ( SGH)
Clinical Associate Professor, Duke- National University Singapore, Singapore
A/Prof Koh ‘s clinical and research interest are in Severe Asthma and Airway diseases. She established the multidisciplinary Singapore General Hospital Severe Asthma Clinic in 2011 and leads a team of doctors, nurses, pharmacists, and other allied health professionals in the SGH Airway Diseases Program. She is also active in various Ministry of Health and Asthma committees, has academic collaborations from various institutions and universities, has >100 publications and sits in editorial boards of a few journals.
Dr Gillianne Lai is a Consultant Medical Oncologist at the National Cancer Centre Singapore. She received her undergraduate training from the Yong Loo Lin School of Medicine, National University of Singapore and is a member of the Royal College of Physicians of the United Kingdom. She completed her Medical Oncology specialty training at the National Cancer Centre Singapore. She has a strong interest in thoracic oncology and is actively involved in research. She currently leads that Lung Cancer Consortium Singapore (LCCS), and is the Principal Investigator of the National Lung Cancer Research (NLCR) study which aims to improve lung cancer care through 4 main themes: (1) understanding the origins of lung cancer, (2) improving risk stratification of disease, (3) identifying better response biomarkers, and (4) understanding resistance mechanisms. She is also the chairperson of the Singhealth Lung Centre Pulmonary Nodule Workgroup and has a keen interest in lung cancer screening.
Dr Lam is Clinical Associate Professor, Chief of Division of Respiratory Medicine, and Deputy Chief of Service of the Department of Medicine, HKU.
He is a respiratory physician with research interests in lung cancer, COPD, smoking and airway physiology. He performs endobronchial ultrasonography and autofluorescence imaging for early detection of lung cancer. He established a lung nodule program to complement lung screening study.
He is on the International Lung Screening Trial Consortium, steering multi-centered lung screening research. In his laboratory, new lung cancer cell lines and organoids serve as models for research in lung cancer.
He is the President of APSR and President of the Forum of International Respiratory Societies (FIRS).
He is Deputy Editor of Respirology and Associate Editor of Respirology Case Report; Honorary Secretary of Hong Kong Lung Foundation (HKLF); and Co-Chairperson of the East Asian Lung Cancer Screening Alliance.
He received multiple research awards including the Tohoku Medical Society Medal (2019), the APSR Woolcock Research Award (2021), and HKLF Donald Yu Lecture (2023).
Thérèse Lapperre is an Associate Professor in Respiratory Medicine at the University of Antwerp and head of the department of Respiratory Medicine at the Antwerp University Hospital (UZA). She has an international background, being trained in the Netherlands (Leiden University) and having worked as a pulmonologist and researcher in both Singapore (Singapore Genral Hospitale) and Copenhagen (Bispebjerg Hospital). Her main research interest involves the pathogenesis and management of patients with COPD and asthma, including clinical and mechanistic studies.
Edmund Lau is an academic respiratory physician working at Royal Prince Alfred Hospital, Sydney and Associate Professor of Medicine at the University of Sydney. He is the lead Respiratory Physician of the Pulmonary Hypertension Service at Royal Prince Alfred Hospital. He is the Medical Director of the Australian and New Zealand Pulmonary Hypertension Registry. He has authored more than 100 peer-reviewed publications, mostly on the topic of pulmonary hypertension. He is Associate Editor of Respirology and he participated in ERS Task Force on pulmonary circulation.
Dr. Kristen Lee is a consultant interventional radiologist, practicing at the Singapore General Hospital (SGH). Dr. Lee completed her diagnostic radiology training at the Mallinckrodt Institute of Radiology, Washington University at St. Louis, and interventional radiology fellowship at University of California, San Francisco, in USA. She is one of the IR leads in establishing the PERT service at SGH and has special clinical interest in percutaneous pulmonary interventions.
Professor YC Gary Lee is a clinician researcher and world leader in Pleural Medicine. He is a Professor of Respiratory Medicine at the University of Western Australia and leads the pleural service at Sir Charles Gairdner Hospital in Perth which is one of the busiest in Australasia. He established the Southern Hemisphere’s first translational pleural program in UWA and founded the Australasian Malignant PLeural Effusion network. His work has translated into clinical practice and informed clinical guidelines on many occasions and improved pleural care worldwide. He has published 300+ papers on pleural diseases (H-index 65), delivered 300+ invited lectures in 32 countries and won successive NHMRC Fellowships. He has trained many next generation pleural specialists from 10+ countries.
Dr. Kyung Soo Lee is a professor in the thoracic imaging section at the Department of Radiology in the Sungkyunkwan University School of Medicine and in the Samsung ChangWon Hospital. His research interests focus on the diagnosis and management of lung cancer, interstitial lung disease, and pulmonary tuberculosis and nontuberculous mycobacterial pulmonary disease (NTM-PD). He is member of the Fleischner Society and an honorary member of European Society of Thoracic Imaging.
Dr. Kang-Yun Lee is Professor of Internal medicine and Vice President of Taipei Medical University (TMU). He also heads the Asthma Assembly of Asian Pacific Society of Respirology. Dr. Lee qualified his first degree of Medicine at TMU and received a PhD in clinical pharmacology at imperial College London in 2006.
Dr. Lee had been working on pathogenesis of asthma, COPD, and lung cancer. In addition to clinically orientated research, he has been working on molecular control of inflammation and immunity in lung diseases. He is interested in microenvironment and immune therapy for lung cancer. His lab identified a novel myeloid-derived suppressor cell (MDSC) in lung cancer, which has been implicated in tumor aggressiveness and drug resistance. Dr. Lee also participates in a great number of clinical trials, in variable lung diseases, including airways diseases, lung cancer and pneumonia.
Lee Pyng is Professor, Yong Loo Lin School of Medicine, National University of Singapore.
She is also Director of Interventional Pulmonology, Division of Respiratory and Critical Care Medicine, National University Hospital. Associate Professor Lee has an active interest in lung cancer, pleural disease, obstructive airway disease, bronchoscopy and pleuroscopy. She was the past President of Singapore Thoracic Society, and serves on international scientific committees in Lung Cancer, Bronchology and Interventional Pulmonology as well as American College of Chest Physician Steering Committees. She represents Singapore as Global Governor for American College of Chest Physicians and is invited locally and overseas to speak and instruct in pleuroscopy, bronchoscopy, bronchial thermoplasty and lung cancer. Associate Professor Lee is the author of publications in peer-reviewed journals, has written a manual and a book on pleuroscopy that worn the British Medical Association Best Book Award in internal medicine in 2011. She received the Young Investigator’s award 2000 for work in asthma, Best Poster Award for research in talc and cancer cells at CHEST 2006, Best Original Investigation and Presentation at Chest World Congress 2014, and the Geoffrey McLennan Award for advancing the field of Interventional Pulmonology at CHEST 2014, Austin, Texas. In 2018, she was conferred AC Shah Oration Award for Woman Researcher in Interventional Pulmonology by Indian Association for Bronchology. She has completed her PhD on New Applications of Bronchoscopic Techniques conferred by Vrije University, Amsterdam in 2014, first in Respiratory medicine
She also received Best Teacher Award in 2012 for undergraduate education, National University Hospital teaching excellence award for post-graduate education in 2014, and the prestigious Outstanding Tutor Award by National University of Singapore Medical Society. She is recently conferred the prestigious Pasquale Ciaglia award by CHEST 2019 for Interventional medicine.
Dr Chi Chiu Leung
Honorary Consultant of the Hong Kong Tuberculosis
Chest and Heart Diseases Association
Dr Chi Chiu Leung graduated from The University of Hong Kong in 1983 and underwent postgraduate training in respiratory medicine and public health, and research fellowship in Stanford University Medical Centre. He previously served as Consultant Chest Physician and headed the Public Service Branch of the Centre for Health Protection, Department of Health, Hong Kong, China. He was the principal investigator of the Hong Kong study site of the Tuberculosis Trial Consortium from 2009 to 2018 and chaired the Pneumoconiosis Medical Board from 1996 to 2018. He previously served in the editorial board of the American Journal of Respiratory and Critical Care Medicine and chief editor of the International Journal of Tuberculosis and Lung Disease. He is currently a deputy editor of Respirology and honorary consultant of the Hong Kong Tuberculosis, Chest and Heart Diseases Association. He has published over 200 articles in peer-review journals with over 10000 citations.
Research leadership: Prof Le Souëf is an academic scientist and respiratory and global health paediatrician. He has published >310 peer-reviewed publications, given >300 invited presentations at international scientific meetings, universities and institutes in 46 different countries, and had research collaborations in North and South America, Africa, Asia and Europe. He was Head, UWA School of Paediatrics for 20 years.
Respiratory research: He was worked in many areas of children’s respiratory research, particularly on early factors influencing children’s respiratory health. He currently heads the Mechanisms of Acute Viral Respiratory Infection in Children (MAVRIC) research team.
Future child health – the effect of environmental decline and increasing world population. He heads a new research group studying the effect of environmental deterioration and overpopulation on future children’s health.
Professor Jing Li Professor, Respiratory Medicine
Director, Department of Allergy and Clinical Immunology
Guangzhou Institute of Respiratory Health
State Key Laboratory of Respiratory Disease
The First Affiliated Hospital
Guangzhou Medical University
Professor of Medicine, Doctoral supervisor, The First Affiliated Hospital of Guangzhou Medical University
Director, Department of Allergy and Clinical Immunology, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Diseases
Member, Asthma Committee, World Society of Allergy (WAO)
Member of the Standing Committee of Allergy Branch of Chinese Medical Doctor Association
Chairman of the Allergy Branch of Guangdong Medical Association, deputy leader of the asthma Group of the Respiratory branch
Guangzhou high-level talent and outstanding expert, Guangdong medical leading talent, Second echelon of “Outstanding Figure Project of South China”
Research grants funded by Natural Science Foundation of China and Ministry of Science and Technology of China for mechanisms of allergen specific immunotherapy, environmental influence of immune regulation in childhood asthma, precision diagnosis and treatment of asthma
Authorship a total of 64 peer-reviewed, 17 review scientific journal articles, and book chapters
Professor Dr. Liam Chong Kin, is an Emeritus Professor of the University of Malaya, Kuala Lumpur and Senior Consultant Respiratory Physician practicing at the Universiti Malaya Medical Centre and UM Specialist Centre.
He is a fellow of the American College of Chest Physicians, Royal College of Physicians (London) and the Asian Pacific Society of Respirology. He is an active member of the International Association for the Study of Lung Cancer, the European Respiratory Society and the Malaysian Thoracic Society. He used to head the Lung Cancer Assembly of APSR.
His clinical and research interests include molecular targeted therapies and immunotherapy for lung cancer. He has published extensively and presented at many regional and international scientific meetings.
Senior consultant at the Department of Respiratory and Critical Care Medicine, Tan Tock Seng Hospital, Singapore. Adjunct Associate Professor, Lee Kong Chian School of Medicine, Nanyang Technological University Singapore and Yong Loo Ling School of Medicine, National University of Singapore. A/Prof. Lim is also a clinical consultant at the Singapore-MIT Alliance for Research and Technology (SMART).
A/Prof. Lim completed his specialist training in respiratory and internal medicine in UK. He has a doctorate in medicine (M.D) awarded at a higher degree from the University of Glasgow. A/Prof. Lim is an expert in airway diseases, pulmonary infection and aspergillus lung diseases. He established and led the Bronchiectasis care programme since 2016 and non-tuberculous mycobacteria (NTM) service since 2019.
A/Prof. Lim is a PI and CO-I of multiple research grants such the NRF grant. His research focus is on clinical outcome prediction of airway diseases such as bronchiectasis, contemporary approach to diagnosis and treatment of bronchiectasis and NTM infection. A/Prof. Lim is also actively involved in new drug discovery and innovation on medical device to improve lung health.
A/Prof. Lim is the principal lead in respiratory medicine of the Lee Kong Chian School of Medicine. He has a strong passion on teaching. He was also served at the ministry of health on various committees.
Dr. Rebecca Chou-Jui Lin is a pulmonologist at Taoyuan General Hospital, Ministry of Health and Welfare, Taiwan. She specializes in tuberculosis (TB) treatment, serves as regional TB consultant, and is one of the board of directors of Taiwan Society of Tuberculosis and Lung Diseases. She has been leading one of the five Taiwan Multidrug-resistant Tuberculosis Consortium (TMTC) teams since 2007, and actively involved in introducing shorter regimens and active drug safety monitoring system for multidrug-resistant TB in Taiwan. She also participated in providing technical assistance regarding uptake of shorter regimen of drug-resistant TB in the Philippines and facilitated in several online international training courses of clinical management of drug-resistant TB over the past few years.
Dr Shaun Loh is a consultant at the Department of Otorhinolaryngology, Head and Neck Surgery (ENT) at Singapore General Hospital. He is also Clinical Assistant Professor at Yong Loo Lin Medical School and Duke-NUS Medical School.
His special interest is in the treatment of Obstructive Sleep Apnea and aims to offer holistic and cutting edge treatment to OSA patients. He has played an integral part in introducing hypoglossal nerve stimulation therapy in Singapore.
Andreas L. Lopata is Professor of Medical Sciences in the College of public health, medical and veterinary sciences at James Cook University, Townsville, Australia. Since 2011 he is head of the Molecular Allergy Research Laboratory in the Australian Institute of Tropical Health and Medicine and since 2021 Prof Research Fellow in the Tropical Futures Institute at James Cook University-Singapore.
He is considered one of the world leaders on food allergies to seafood and has contributed to the development of national and international guidelines. His predominant focus has been on developing and employing advanced molecular technologies to investigate allergenic proteins, understand the interactions of allergens with the immune system and to develop novel interventions and therapeutics for food allergy.
Prof Lopata is principal investigator in the Centre for Food Allergy Research, a NHMRC Centre for Research Excellence since 2013, and the National Allergy Centre of Excellence, aiming at the facilitation and acceleration of allergy research to reduce the incidence of food allergies and translation into clinical practice.
He promotes translational science with over 250 publication and editorial board support on leading journals, including section editor Asia-Pacific of the WAO World Allergy Organisation Journal.
Dr Low is currently a Senior Consultant in the Department of Respiratory & Critical Care Medicine at the Singapore General Hospital.
Her special interest is in Interstitial Lung Disease for which she spent some time at the Royal Brompton Hospital, United Kingdom, learning from world renowned physicians in this area.
She is a Clinical Senior Lecturer at the NUS Yong Loo Lin School of Medicine; Clinical Associate Professor, Duke-NUS Medical School; Physician Faculty, SingHealth Respiratory Medicine Senior Residency Programme; Clinical Teacher at the Lee Kong Chian School of Medicine, Singapore.
Chong Ying is a Senior Dietitian with Tan Tock Seng Hospital. She graduated from Curtin University with a Masters of Dietetics. She has clinical experience in working with a wide range of patients to improve their nutritional knowledge and intake, and to manage their acute and/or chronic diseases. Her keen areas of interest are in respiratory disease and intermediate rehabilitation, where she strives to collaborate with stakeholders, deliver evidence-based and patient-centred nutrition care and improve patients’ quality of life.
Dr. Lui is the consultant physician of Queen Mary Hospital and the honorary clinical associate professor of The University of Hong Kong. She is the Director of Cluster Sleep Service, Hong Kong West Cluster. She received her undergraduate training at the Li Ka Shing Faculty of Medicine, The University of Hong Kong (HKU). After a series of research endeavour on sleep disordered breathing, she also attained Doctor of Medicine (MD) HKU, with research focus on biomarkers in cardio-metabolic complications of obstructive sleep apnoea. She is currently the Honorary Secretary of the Hong Kong Thoracic Society. She has numerous publications in peer-reviewed journals and textbooks, and is currently the Deputy Editor of Respirology, the official journal of the Asia Pacific Society of Respirology.